ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, invites investors to view a transcript of the Company’s recent investor conference call, during which President Dr. Mark Landy recapped the Company’s major achievements for the first half of 2007 and detailed the Company’s strategic initiatives for the year ahead and beyond.